A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vulnerability to relapse.
A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vulnerability to relapse.
复制标题
DOI:
10.1007/s00213-020-05750-2
复制
发表时间:
2021-04
影响因子:
3.4
通讯作者:
Lynch WJ
中科院分区:
文献类型:
--
作者:
Bakhti-Suroosh A;Towers EB;Lynch WJ
Opioid use disorder (OUD) is a major epidemic in the USA. Despite evidence indicating that OUD may be particularly severe for women, preclinical models have yet to establish sex as a major factor in OUD. Here, we examined sex differences in vulnerability to relapse following intermittent access fentanyl self-administration and protracted abstinence and used buprenorphine, the FDA-approved treatment for OUD, to test the validity of our model. Following acquisition of fentanyl self-administration under one of two training conditions, male and female rats were given extended, 24-h/day access to fentanyl (0.25 μg/kg/infusion, 10 days) using an intermittent access procedure. Vulnerability to relapse was assessed using an extinction/cue-induced reinstatement procedure following 14 days of abstinence; buprenorphine (0 or 3 mg/kg/day) was administered throughout abstinence. Levels of drug-seeking were high following extended-access fentanyl self-administration and abstinence; buprenorphine markedly decreased drug-seeking supporting the validity of our relapse model. Females self-administered more fentanyl and responded at higher levels during subsequent extinction testing. Buprenorphine was effective in both sexes and eliminated sex and estrous phase differences in drug-seeking. Interestingly, the inclusion of a time-out during training had a major impact on later fentanyl self-administration in females, but not males, indicating that the initial exposure conditions can persistently impact vulnerability in females. These findings demonstrate the utility of this rat model for determining sex and hormonal influences on the development and treatment of OUD.
登录
查看更多内容
影响因子:
3.9
作者:
Fenn, Jennifer M.;Laurent, Jennifer S.;Sigmon, Stacey C.
通讯作者:
Sigmon, Stacey C.
影响因子:
3.4
作者:
Allain, Florence;Bouayad-Gervais, Karim;Samaha, Anne-Noel
通讯作者:
Samaha, Anne-Noel
影响因子:
2.7
作者:
ANGLIN, MD;HSER, YI;MCGLOTHLIN, WH
通讯作者:
MCGLOTHLIN, WH
影响因子:
10.6
作者:
Bossert, Jennifer M.;Kiyatkin, Eugene A.;Shaham, Yavin
通讯作者:
Shaham, Yavin
影响因子:
3.6
作者:
Cicero, TJ;Aylward, SC;Meyer, ER
通讯作者:
Meyer, ER